300122.SZ
智飞生物
SZSE · Healthcare · C 制造业 · CN
CNY 12.83
−7.70%Margins
Gross margin
6.6%
EBITDA margin
-193.5%
EBIT margin
-200.3%
Net margin
-168.9%
FCF margin
52.5%
-95.7%
Return on equity
-50.8%
Return on assets
-75.0%
Return on invested capital
0.29x
Asset turnover
CNY 5.1B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026